Overview of Quality Grade Change and Market Context
On 5 May 2026, Primo Chemicals Ltd’s quality grade was revised downward from good to average, signalling a moderation in the company’s fundamental strength. The Mojo Score currently stands at 61.0, with a Hold rating, an improvement from the previous Sell grade. This reflects a cautious optimism amid some deteriorating financial parameters. The stock price closed at ₹25.07 on 7 May 2026, down 1.61% from the previous close of ₹25.48, trading within a 52-week range of ₹16.21 to ₹31.44.
Over the short term, Primo Chemicals has outperformed the Sensex, delivering a 9.9% return in the past week and 11.4% over the last month, compared to Sensex gains of 0.6% and 5.2% respectively. Year-to-date, the stock has gained 4.7%, while the Sensex declined by 8.5%. However, the longer-term picture is less favourable, with a three-year return of -66.1% versus Sensex’s 27.7%, and a five-year return of 23.2% lagging behind the Sensex’s 59.3%.
Profitability and Return Metrics: ROE and ROCE Analysis
Return on Equity (ROE) and Return on Capital Employed (ROCE) are key indicators of a company’s efficiency in generating profits from shareholders’ equity and total capital respectively. Primo Chemicals’ average ROE stands at 11.9%, while its average ROCE is slightly higher at 12.8%. These figures place the company in the average category within its peer group, which includes firms like Titan Biotech and Stallion India, also graded average on quality.
While these returns are positive, they are modest relative to industry benchmarks and have not shown significant improvement over recent years. The company’s ability to generate returns above its cost of capital remains marginal, which may explain the downgrade in quality grade. Investors typically favour companies with ROE and ROCE consistently above 15%, signalling robust profitability and capital utilisation.
Growth Trends: Sales and EBIT Performance
One of the more concerning aspects of Primo Chemicals’ fundamentals is the decline in earnings before interest and tax (EBIT). Over the past five years, the company’s EBIT has contracted at a steep annualised rate of -30.9%, a sharp deterioration that contrasts with a modest sales growth of 5.5% over the same period. This divergence suggests rising costs or operational inefficiencies impacting profitability despite top-line expansion.
The average sales to capital employed ratio is 1.08, indicating that the company generates just over a rupee of sales for every rupee invested in capital. While this is not alarming, it does not reflect strong capital productivity, especially when coupled with declining EBIT. The tax ratio remains elevated at 37.2%, which further compresses net profitability.
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
Debt Profile and Interest Coverage
Primo Chemicals carries a moderate debt burden, with an average net debt to equity ratio of 0.32. This level of leverage is manageable but not negligible for a micro-cap company in the commodity chemicals sector. The average debt to EBITDA ratio of 4.63 indicates that the company’s earnings before interest, tax, depreciation and amortisation cover its debt obligations less than five times, which is borderline for comfort.
Interest coverage, measured by EBIT to interest expense, averages 5.77 times. While this suggests the company can service its interest payments, the declining EBIT trend raises concerns about sustainability. A weakening operating profit base could pressure interest coverage ratios going forward, increasing financial risk.
Shareholding and Dividend Payout
Institutional holding in Primo Chemicals is low at 2.0%, reflecting limited institutional confidence or interest. The company has no pledged shares, which is a positive sign indicating no encumbrances on promoter holdings. However, the dividend payout ratio is not specified, suggesting either irregular dividend payments or a conservative dividend policy, which may affect investor appeal.
Comparative Industry Positioning
Within the commodity chemicals sector, Primo Chemicals is rated average in quality alongside peers such as Titan Biotech, Stallion India, and Sanstar. Some competitors like Gulshan Polyols and Oriental Aromatics are rated below average, indicating a mixed sectoral landscape. Primo’s micro-cap status and middling fundamentals place it in a challenging position to attract significant investor interest compared to larger, better-performing peers.
Holding Primo Chemicals Ltd from Commodity Chemicals? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Implications for Investors
The downgrade in Primo Chemicals’ quality grade from good to average reflects a combination of deteriorating profitability, modest returns, and moderate leverage. The sharp decline in EBIT over five years is particularly concerning, signalling operational challenges that have not been offset by sales growth. While the company’s ROE and ROCE remain positive, they are not sufficiently robust to inspire strong confidence.
Investors should weigh the company’s recent outperformance against the Sensex in the short term with the longer-term fundamental weaknesses. The Hold rating and Mojo Score of 61.0 suggest a cautious stance, recommending monitoring for signs of operational turnaround or improvement in capital efficiency before committing fresh capital.
Given the low institutional interest and limited dividend visibility, Primo Chemicals may appeal more to speculative investors willing to tolerate volatility rather than those seeking stable income or growth. The company’s micro-cap status also implies higher risk and lower liquidity compared to larger peers.
Conclusion
Primo Chemicals Ltd’s recent quality grade downgrade is a clear signal that the company’s fundamentals have softened, particularly in profitability and operational efficiency. While the stock has shown resilience in the near term, the underlying financial metrics warrant caution. Investors should closely monitor future earnings trends, debt servicing ability, and capital returns before revising their investment stance.
In the competitive commodity chemicals sector, Primo Chemicals faces challenges in sustaining growth and improving returns. Until these issues are addressed, the company’s average quality grade and Hold rating are likely to persist.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
